New NIOSH Research Paves Pathway For Stricter COVID-19 Health Care Rule

The National Institute of Occupational Safety and Health (NIOSH) has released a slew of new research on the effectiveness of workplace COVID-19 controls, including those related to masking and distancing, with advice that could bolster the case for tough new safety measures in OSHA’s permanent COVID-19 standard for the health care sector. Speaking at a Feb. 22 meeting of the National Advisory Committee on Occupational Safety and Health (NACOSH), NIOSH Director John Howard presented several recently published reports from the...
Article Type: 
Site Name:
FDA Issue: 
FDA Week - 03/04/2022
FDA Volume: 
Vol. 28, No. 9

Oregon Scraps Closed-Formulary Plan But Seeks To Deny Accelerated Approval Drugs

Oregon is withdrawing its request for a closed drug formulary in the face of opposition from the drug industry and patient groups, but state Medicaid officials are still asking for permission to exclude accelerated approval drugs from its formularies until drug makers complete post-market studies, according to the state’s broader request that CMS waive certain Medicaid requirements . If CMS were to let Oregon exclude accelerated approval drugs, that precedent would open the door for closed formularies in other states...
Article Type: 
Site Name:
IDP Issue: 
Inside Drug Pricing - 02/28/2022
IDP Volume: 
Vol. 5, No. 9


Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.